{
    "2020-01-31": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study",
                "features": {
                    "keywords": [
                        "Olumiant",
                        "Late-Stage",
                        "Eczema",
                        "Succeeds"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Earnings Miss: Pfizer Inc. Missed EPS By 16% And Analysts Are Revising Their Forecasts",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Miss",
                        "Pfizer",
                        "EPS",
                        "Analysts",
                        "Revising"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "LLY",
                        "PFE",
                        "Q4",
                        "Results",
                        "JNJ",
                        "Coronavirus",
                        "Vaccine"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Bayer Seeks FDA Approval for New Formulation of Nifurtimox",
                "features": {
                    "keywords": [
                        "Bayer",
                        "FDA",
                        "Approval",
                        "Nifurtimox",
                        "Formulation"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCEâ„¢ (rituximab)",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CHMP",
                        "Opinion",
                        "Oncology",
                        "Biosimilar",
                        "RUXIENCE"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Bayer wins EU recommendation for prostate cancer drug",
                "features": {
                    "keywords": [
                        "Bayer",
                        "EU",
                        "Recommendation",
                        "Prostate",
                        "Cancer",
                        "Drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}